Literature DB >> 10425182

Balloon injury does not induce heme oxygenase-1 expression, but administration of hemin inhibits neointimal formation in balloon-injured rat carotid artery.

T Aizawa1, N Ishizaka, J Taguchi, S Kimura, K Kurokawa, M Ohno.   

Abstract

It has been shown that antioxidant agents act inhibitorily against neointimal formation after balloon injury, suggesting the role of oxidative stress as a promotor of intimal cell proliferation. Heme oxygenase-1 (HO-1) is an inducible form of heme catabolizing enzyme that is induced by and acts against oxidative tissue injury. In this set of experiments, we showed that HO-1 was present in newly formed neointima; however, arterial HO-1 expression did not increase in response to balloon injury in rat carotid artery. Intraperitoneal administration of hemin, a HO-1 inducer, for 5 consecutive days resulted in about a 4-fold increase of serum bilirubin concentration. In addition, hemin injection increased HO-1 protein expression in the carotid artery, the heart, the kidney, and the liver. In this condition, balloon injury-induced neointimal formation was markedly inhibited. Local application of tin protoporphyrin, a HO inhibitor, blocked this effect, suggesting that induced HO-1 in the carotid artery was responsible for the inhibition of neointimal formation after balloon injury. This study suggests that induction of the endogenous antioxidant gene can suppress neointimal formation after balloon injury. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425182     DOI: 10.1006/bbrc.1999.1020

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Novel therapies for cyclic GMP control of vascular smooth muscle growth.

Authors:  David A Tulis
Journal:  Am J Ther       Date:  2008 Nov-Dec       Impact factor: 2.688

2.  Local administration of carbon monoxide inhibits neointima formation in balloon injured rat carotid arteries.

Authors:  D A Tulis; A N Keswani; K J Peyton; H Wang; A I Schafer; W Durante
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2005-10-03       Impact factor: 1.770

Review 3.  Heme Oxygenases in Cardiovascular Health and Disease.

Authors:  Anita Ayer; Abolfazl Zarjou; Anupam Agarwal; Roland Stocker
Journal:  Physiol Rev       Date:  2016-10       Impact factor: 37.312

4.  Total, direct, and indirect serum bilirubin concentrations and metabolic syndrome among the Korean population.

Authors:  Jaeseong Jo; Ji Eun Yun; Heeyeon Lee; Heejin Kimm; Sun Ha Jee
Journal:  Endocrine       Date:  2010-11-30       Impact factor: 3.633

Review 5.  Targeting heme oxygenase-1 in vascular disease.

Authors:  William Durante
Journal:  Curr Drug Targets       Date:  2010-12       Impact factor: 3.465

6.  Butylated hydroxyanisole stimulates heme oxygenase-1 gene expression and inhibits neointima formation in rat arteries.

Authors:  Xiao-ming Liu; Mohammed A Azam; Kelly J Peyton; Diana Ensenat; Amit N Keswani; Hong Wang; William Durante
Journal:  Cardiovasc Res       Date:  2007-01-27       Impact factor: 10.787

7.  Bilirubin inhibits neointima formation and vascular smooth muscle cell proliferation and migration.

Authors:  Kelly J Peyton; Ahmad R Shebib; Mohammad A Azam; Xiao-Ming Liu; David A Tulis; William Durante
Journal:  Front Pharmacol       Date:  2012-03-22       Impact factor: 5.810

8.  Antioxidants protect from atherosclerosis by a heme oxygenase-1 pathway that is independent of free radical scavenging.

Authors:  Ben J Wu; Krishna Kathir; Paul K Witting; Konstanze Beck; Katherine Choy; Cheng Li; Kevin D Croft; Trevor A Mori; David Tanous; Mark R Adams; Antony K Lau; Roland Stocker
Journal:  J Exp Med       Date:  2006-04-10       Impact factor: 14.307

Review 9.  Role of carbon monoxide in cardiovascular function.

Authors:  William Durante; Fruzsina K Johnson; Robert A Johnson
Journal:  J Cell Mol Med       Date:  2006 Jul-Sep       Impact factor: 5.310

10.  Association of serum total bilirubin levels with diastolic dysfunction in heart failure with preserved ejection fraction.

Authors:  Huan Zheng; Ye Li; Nanzi Xie
Journal:  Biol Res       Date:  2014-03-26       Impact factor: 5.612

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.